News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Suzuken Co., Ltd Invests In Glucon; Suzuken Co. To Launch Glucon's Glucose Monitoring Watch -- GMW -- In Japan


10/19/2005 5:12:30 PM

BOULDER, Colo.--(BUSINESS WIRE)--Dec. 20, 2004--Glucon, developer of a continuous, noninvasive, glucose monitoring technology for home and clinical use, today named Suzuken Co., Ltd (TSE:9987), Japan's largest pharmaceuticals distributor, as one of the company's strategic investors. Suzuken Co.'s equity investment in Glucon is part of the $14.8 million financing round made public in September 2004. Triangle Technologies was instrumental in helping to form the current strategic relationship between Glucon and Suzuken.

Read at BioSpace.com


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES